The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
from Medindia Health News https://ift.tt/3HVqnkL
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
November 25, 2021
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.